Market Research Report - 250401
Pharma Reputations: Managing Perceptions
|Published||Content info||69 Pages|
Pharma is no stranger to the idea of nurturing and defending corporate reputations. But in this hyper-connected world, Likes and Tweets are replacing traditional authority sources and creating a completely new communications landscape, in which news, especially bad news, travels faster than ever before.
In this climate, it's essential for organisations to go beyond a corporate social responsibility programme and really understand, and respond to, the expectations and needs of different stakeholders. Companies often need to implement new organisational structures to manage perceptions more effectively.
At most companies, there is a will to invest in reputation management, but the internal know-how and resources may not be there yet. Questions still need to be answered: What is our reputation? Does our reputation really matter? And if it does, what can we do about it?
This comprehensive report is designed to help anyone with a leadership role in reputation management navigate the rapidly changing communications environment.
With this invaluable resource you'll be able to identify the factors that matter most to Pharma's key stakeholders and to the public at large, and to ensure that capabilities are in place to protect against risks and exploit opportunities as they arise.
The report closely examines the latest research and industry practices to provide an overview of key current issues affecting reputation, data on the real financial impact of reputation management, insights into the expectations of shareholders and customers, and best practices on reputation management in the Pharma industry.
You'll also get an in-depth look at five different approaches to reputation management, with detailed case studies from companies at various points on the way to making reputation thinking fully integrated into every strategic decision.
"We have one thing going for us and that is we make products that help
people either survive or live better lives. That's the big plus we have as an
industry compared with many others and that is what we must focus on."
Mike Rulis, global head of communications, Novo Nordisk
"Doing something because it's the right thing to do has run its course. Now
it's reputation, because people are asking hard questions about the companies
behind the services they buy. If you can't answer, they will rate you poorly."
Anthony Johndrow, managing partner, Reputation Institute
"The expectation of consumers has changed so much over the years that, in
addition to a relationship with a given brand or product, they want to know
the company behind it stands for something meaningful and something good."
Jon Richter, senior director, Reputation & Policy Communications, Pfizer